Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03271528 · ClinicalTrials.gov registry record · Phase 1
Lacosamide Effects on Alcohol Self Administration and Craving in Heavy Drinkers
A Phase 1 study, sponsored by Boston Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 66
- Enrollment target
NCT03271528 is a Phase 1 study that has completed, run by Boston Medical Center. The registered enrollment target is 66 participants.
The verdict
NCT03271528, a Phase 1 study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 66 participants
- Enrollment target
Study Summary
This is a double-blind, randomized, placebo-controlled, crossover design trial tested the effect of lacosamide on alcohol self-administration and craving following a priming dose of alcohol. The specific objective of this study was to determine whether lacosamide, a novel anticonvulsant that is FDA-approved for treating partial seizures, has effects on alcohol craving and consumption.
Interventions
- DRUG Placebo oral capsule
- DRUG Lacosamide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 66 participants |
| Start Date | 2018-04-15 |
| Est. Completion | 2020-08-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03271528
The ClinicalTrials.gov registry entry for NCT03271528 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo oral capsule is the first listed.
NCT03271528 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03271528 about?
NCT03271528 is a clinical study titled "Lacosamide Effects on Alcohol Self Administration and Craving in Heavy Drinkers". This is a double-blind, randomized, placebo-controlled, crossover design trial tested the effect of lacosamide on alcohol self-administration and craving following a priming dose of alcohol. The specific objective of this study was to determine whether lacosamide, a novel anticonvulsant that is FDA-...
What is the current status of trial NCT03271528?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 66 participants. The study started on 2018-04-15. Estimated completion is 2020-08-31.
What interventions are being tested in trial NCT03271528?
The interventions under investigation include: Placebo oral capsule (DRUG), Lacosamide (DRUG).
Who is sponsoring clinical trial NCT03271528?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.